drugset / Trial / NCT01251380
Dysport® Pediatric Lower Limb Spasticity Follow-on Study
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this research study was to determine the long term safety and efficacy of repeated treatments with Dysport® used in the treatment of lower limb spasticity in children with dynamic equinus foot deformity due to cerebral palsy.
Timeline
- Start
- 2011-10
- Primary completion
- 2015-01
- Completion
- 2015-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 5 iu/kg | Intramuscular |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 10 iu/kg | Intramuscular |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 20 iu/kg | Intramuscular |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 30 iu/kg | Intramuscular |
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 1000 iu | Intramuscular |